Back to Medicines

Statins and Muscle Pain: What the Evidence Says

Statins and Muscle Pain: What the Evidence Says
Prescription Medicines Editorial 20 September 2026

Muscle aches are the most frequently reported statin side effect and the most common reason people stop taking one. The honest summary of the evidence is this: severe muscle damage from statins is rare and real, everyday aches are extremely common in the age group that takes statins whether or not they are on one, and blinded trials find far less difference between statin and placebo than the reporting rate suggests. That does not mean your aches are imaginary. It means the cause is worth establishing properly, because the answer changes what to do next.

Never stop a statin on the strength of an article. There is a straightforward way to find out, and it is described below.

What statins are doing

Statins block an enzyme the liver uses to make cholesterol. The liver responds by pulling more LDL cholesterol out of the blood, which lowers circulating levels. They also appear to stabilise existing fatty plaques in artery walls, making them less likely to rupture and cause a heart attack or stroke - an effect thought to be partly independent of the cholesterol reduction itself.

They are prescribed either after a cardiovascular event or where a risk calculation suggests the reduction is worthwhile. Because they are preventive, you will never feel them working. That asymmetry - no perceptible benefit, perceptible aches - explains a great deal about why they get stopped.

What the blinded trials found

In large randomised trials, the rate of muscle symptoms among people taking a statin is only slightly higher than among people taking a placebo. The gap accounts for a small fraction of what is reported in ordinary practice.

More striking are the n-of-1 studies, in which individuals who had stopped statins because of muscle pain took alternating periods of statin and placebo without knowing which was which. Most reported similar symptoms in both periods, and a substantial proportion went back onto a statin afterwards, having established that the drug was not the cause.

Part of what is happening is the nocebo effect: expecting a side effect makes you notice and attribute sensations you would otherwise have ignored. That is not a polite way of saying the pain is invented. It is a description of how attention works, and it applies to everyone.

Where the real risk sits

Serious statin muscle injury exists and should not be dismissed. Myopathy - genuine muscle inflammation with raised creatine kinase in the blood - is uncommon. Rhabdomyolysis, the severe form in which muscle breakdown products damage the kidneys, is rare but a medical emergency.

Contact a doctor promptly if you have severe or widespread muscle pain, real weakness rather than aching, or urine that turns dark like tea or cola. That combination is not a side effect to put up with.

The risk rises with higher doses, with certain other medicines, and with underlying thyroid or kidney problems. Some antibiotics and antifungals slow the breakdown of particular statins and push levels up sharply, which is why you should always mention your statin when starting anything new. Grapefruit juice does the same thing with some statins - our guide to interactions worth knowing about explains that mechanism.

Aches that turn out to be something else

Statins are taken mostly by people over fifty, an age at which musculoskeletal aches are near-universal. Before concluding the tablet is responsible, it is worth ruling out an underactive thyroid, vitamin D deficiency, polymyalgia rheumatica, osteoarthritis, a recent change in activity, and other medicines. A blood test settles several of those.

The timing is informative too. Statin-related symptoms usually appear within weeks of starting or of a dose change, and typically affect large muscle groups on both sides - thighs, shoulders, upper arms. Pain in one joint, or aches that began years into treatment with no change, points elsewhere.

What to do instead of stopping

Speak to your GP or pharmacist, who has several options that do not involve abandoning treatment. A short supervised break clarifies whether symptoms actually track the drug. A lower dose, a different statin, or less frequent dosing of a long-acting one all help some people, because statins differ in how they are broken down and how much reaches muscle tissue. Where a statin genuinely cannot be tolerated, other cholesterol-lowering drugs exist.

The reason for going through this rather than simply stopping is that the benefit is real, particularly for anyone who has already had a heart attack or stroke. Stopping quietly and saying nothing at the next review is the outcome worth avoiding - it leaves you with the cardiovascular risk and your record showing treatment you are not taking.

Other things people ask about

Statins slightly increase the chance of developing type 2 diabetes, mostly in people already close to the threshold. In those at high cardiovascular risk, the reduction in heart attacks and strokes is generally judged to outweigh it, but it is a fair thing to discuss.

Liver enzymes are usually checked before starting and again a few months in. Mild rises are common and rarely require stopping. Memory complaints have been reported, but trials have not established a consistent effect.

Taking a statin does not make diet and exercise irrelevant. They act on different parts of the same risk, and the guidance on blood pressure, smoking and weight applies just as much to someone on treatment.

If you have decided you no longer want to take it, say so at your review rather than stopping silently. There is usually more room to negotiate than people expect, and a plan you will actually follow beats a prescription you quietly ignore.

See also Do You Have to Take Statins for Life?, and the Medicines section for more on how the main families of medicine work.